Bookrunner Jefferies and co-manager Leerink Swann assist with sale
By Devika Patel
Knoxville, Tenn., Jan. 25 - Anthera Pharmaceuticals, Inc. said it priced a $40 million public sale of stock with a $6 million greenshoe. The deal was announced on Thursday.
The company will sell 60,606,061 common shares at $0.66 apiece. The price per share is an 8.33% discount to the Jan. 24 closing share price of $0.72.
Jefferies is the bookrunning manager, and Leerink Swann is the co-manager.
Settlement is expected on Jan. 30.
Proceeds will be used for general corporate purposes.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $40 million
|
| Greenshoe: | $6 million
|
| Shares: | 60,606,061
|
| Price: | $0.66
|
| Warrants: | No
|
| Bookrunner: | Jefferies
|
| Co-managers: | Leerink Swann
|
| Announcement date: | Jan. 24
|
| Pricing date: | Jan. 25
|
| Settlement date: | Jan. 30
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $0.72 at close Jan. 24
|
| Market capitalization: | $51.21 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
